Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Autologous Haematopoietic Stem Cell Transplant”

133 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 133 results

Post-approval studies (Phase 4)Study completedNCT05087212
What this trial is testing

Mobilization of Stem Cells With AMD3100 (Plerixafor) in Combination With G-CSF in Multiple Myeloma Patients

Who this might be right for
Autologous Haematopoietic Stem Cell Transplant
Sanofi 53
Not applicableWithdrawnNCT02225795
What this trial is testing

Pilot Study of Stem Cell Transplantation for Children and Young Adults With Refractory Crohn's Disease.

Who this might be right for
Crohn's Disease
TriStar Health
Early research (Phase 1)Looking for participantsNCT06647979
What this trial is testing

Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Severe β-Hemoglobinopathies

Who this might be right for
Sickle Cell DiseaseSickle Cell Anemia (HbSS, or HbSβ-thalassemia0)Beta-Thalassemia+1 more
Daniel Bauer 10
Testing effectiveness (Phase 2)Study completedNCT00005985
What this trial is testing

Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Masonic Cancer Center, University of Minnesota 213
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06449625
What this trial is testing

Semaglutide in Auto-HSCT

Who this might be right for
Intestinal MucositisInflammationChemotherapeutic Toxicity
Klaus Gottlob Müller 40
Testing effectiveness (Phase 2)Study completedNCT02331368
What this trial is testing

Phase 2 Multi-center Study of Anti-PD-1 During Lymphopenic State After HDT/ASCT for Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Michigan Rogel Cancer Center 32
Testing effectiveness (Phase 2)Study completedNCT00073918
What this trial is testing

Iodine I 131 Tositumomab, Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Anaplastic Large Cell LymphomaCutaneous B-cell Non-Hodgkin LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue+14 more
Fred Hutchinson Cancer Center 111
Testing effectiveness (Phase 2)Study completedNCT01130194
What this trial is testing

Immunochemotherapy, Zevalin, and Bone Marrow Transplant for Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
St. Louis University 29
Large-scale testing (Phase 3)WithdrawnNCT05063513
What this trial is testing

Autologous Stem Cell Transplantation: International Lupus Trial

Who this might be right for
REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS
European Society for Blood and Marrow Transplantation
Large-scale testing (Phase 3)Study completedNCT01241708
What this trial is testing

Tandem Auto Stem Cell Transplant With Melphalan Followed by Melphalan and Bortezomib in Patients With Multiple Myeloma

Who this might be right for
Multiple MyelomaAuto Stem Cell Transplant
Hackensack Meridian Health 148
Testing effectiveness (Phase 2)Ended earlyNCT02681302
What this trial is testing

Check Point Inhibition After Autologous Stem Cell Transplantation in Patients at High Risk of Post Transplant Recurrence

Who this might be right for
Multiple MyelomaLymphoma
Hackensack Meridian Health 46
Not applicableStudy completedNCT02504190
What this trial is testing

Non-interventional Study on TEAM Conditioning in Patients With Lymphoma (TEAM)

Who this might be right for
Lymphoma
Association for Training, Education, and Research in Hematology, Immunology, and Transplantation 95
Not applicableStudy completedNCT04227340
What this trial is testing

Prevention of Oral Mucositis Using Photobiomodulation Therapy

Who this might be right for
Oral Mucositis
St. Jude Children's Research Hospital 43
Testing effectiveness (Phase 2)Looking for participantsNCT07188090
What this trial is testing

Mozobil for Autologous Hematopoietic Stem Cell Transplantation

Who this might be right for
Multiple MyelomaHodgkin LymphomaNon-hodgkin Lymphoma
Thomas Jefferson University 100
Not applicableStudy completedNCT00274794
What this trial is testing

VP and G-CSF With or Without Rituximab in Autologous Peripheral Stem Cell Transplant For NHL

Who this might be right for
Lymphoma
The Cleveland Clinic 55
Early research (Phase 1)Not Yet RecruitingNCT07708350
What this trial is testing

Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseSickle Cell Anemia (HbSS, or HbSβ-thalassemia0)
Daniel Bauer 5
Testing effectiveness (Phase 2)Ended earlyNCT01679041
What this trial is testing

High Dose Chemo With Stem Cell Transplant as Treatment for Multiple Sclerosis That Failed Prior Treatment

Who this might be right for
Multiple Sclerosis
Seah Lim M.D. 1
Large-scale testing (Phase 3)Looking for participantsNCT07413809
What this trial is testing

Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen

Who this might be right for
Multiple Myeloma
The Affiliated People's Hospital of Ningbo University 92
Not applicableLooking for participantsNCT07635693
What this trial is testing

ATLG Levels in Autologous HSCT for Multiple Sclerosis

Who this might be right for
Multiple SclerosisAutologous Hematopoietic Stem Cell TransplantATLG
Ciceri Fabio 20
Testing effectiveness (Phase 2)Study completedNCT00007995
What this trial is testing

Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Herbert Irving Comprehensive Cancer Center 75
Next Page